12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. Infinity Pharmaceuticals, Vivos Therapeutics, Cardiff Oncology, Fresh2 Group, Tilray Brands, and electroCore saw their stocks rise by 60.9%, 59.0%, 35.03%, 28.12%, 27.59%, and 22.75% respectively. On the other hand, Vistagen Therapeutics, Mallinckrodt, Tempest Therapeutics, Arcturus Therapeutics, Axogen, and FibroGen saw their stocks fall by 37.7%, 21.83%, 19.42%, 19.25%, 18.79%, and 18.65% respectively. The Q2 earnings reports for Arcturus Therapeutics, Axogen, and FibroGen were released yesterday.
August 08, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cardiff Oncology stock rose by 35.03% during Tuesday's session.
The significant rise in Cardiff Oncology's stock price could be due to positive market sentiment or company-specific news. This could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
electroCore stock rose by 22.75% during Tuesday's session.
The significant rise in electroCore's stock price could be due to positive market sentiment or company-specific news. This could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Fresh2 Group stock rose by 28.12% during Tuesday's session.
The significant rise in Fresh2 Group's stock price could be due to positive market sentiment or company-specific news. This could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Infinity Pharmaceuticals stock rose by 60.9% during Tuesday's session.
The significant rise in Infinity Pharmaceuticals' stock price could be due to positive market sentiment or company-specific news. This could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Tilray Brands stock rose by 27.59% during Tuesday's session.
The significant rise in Tilray Brands' stock price could be due to positive market sentiment or company-specific news. This could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vivos Therapeutics stock rose by 59.0% during Tuesday's session.
The significant rise in Vivos Therapeutics' stock price could be due to positive market sentiment or company-specific news. This could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Arcturus Therapeutics stock fell by 19.25% during Tuesday's session. The company's Q2 earnings report was released yesterday.
The significant fall in Arcturus Therapeutics' stock price could be due to the company's Q2 earnings report. This could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Axogen stock fell by 18.79% during Tuesday's session. The company's Q2 earnings report was released yesterday.
The significant fall in Axogen's stock price could be due to the company's Q2 earnings report. This could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
FibroGen stock fell by 18.65% during Tuesday's session. The company's Q2 earnings report was released yesterday.
The significant fall in FibroGen's stock price could be due to the company's Q2 earnings report. This could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Mallinckrodt stock fell by 21.83% during Tuesday's session.
The significant fall in Mallinckrodt's stock price could be due to negative market sentiment or company-specific news. This could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Tempest Therapeutics stock fell by 19.42% during Tuesday's session.
The significant fall in Tempest Therapeutics' stock price could be due to negative market sentiment or company-specific news. This could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Vistagen Therapeutics stock fell by 37.7% during Tuesday's session.
The significant fall in Vistagen Therapeutics' stock price could be due to negative market sentiment or company-specific news. This could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100